{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T02:41:55Z","timestamp":1791859315935,"version":"4.3.4"},"reference-count":47,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,4,23]],"date-time":"2019-04-23T00:00:00Z","timestamp":1555977600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["amjtransplant.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Transplantation"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1111\/ajt.15397","type":"journal-article","created":{"date-parts":[[2019,4,23]],"date-time":"2019-04-23T05:47:13Z","timestamp":1555998433000},"page":"2865-2875","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":88,"title":["Safety and efficacy of eculizumab for the prevention of antibody-mediated rejection after deceased-donor kidney transplantation in patients with preformed donor-specific antibodies"],"prefix":"10.1016","volume":"19","author":[{"given":"Denis","family":"Glotz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graeme","family":"Russ","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lionel","family":"Rostaing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1743-2948","authenticated-orcid":false,"given":"Christophe","family":"Legendre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gunnar","family":"Tufveson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steve","family":"Chadban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josep","family":"Griny\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nizam","family":"Mamode","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Rigotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lionel","family":"Couzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"B\u00fcchler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvio","family":"Sandrini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bradley","family":"Dain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"Garfield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masayo","family":"Ogawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tristan","family":"Richard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William H.","family":"Marks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1111\/ajt.15397_bib1","doi-asserted-by":"crossref","first-page":"471","DOI":"10.2215\/CJN.05021107","article-title":"Kidney transplantation as primary therapy for end-stage renal disease: a National Kidney Foundation\/Kidney Disease Outcomes Quality Initiative (NKF\/KDOQI\u2122) conference","volume":"3","author":"Abecassis","year":"2008","journal-title":"Clin J Am Soc Nephrol."},{"issue":"1-4","key":"10.1111\/ajt.15397_bib2","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1159\/000360023","article-title":"UK Renal Registry 16th annual report: chapter 4 demography of patients waitlisted for renal transplantation in the UK: national and centre-specific analyses","volume":"125","author":"Pruthi","year":"2013","journal-title":"Nephron Clin Pract."},{"key":"10.1111\/ajt.15397_bib3","doi-asserted-by":"crossref","first-page":"7903471","DOI":"10.1155\/2017\/7903471","article-title":"Not all antibodies are created equal: factors that influence antibody mediated rejection","volume":"2017","author":"Butler","year":"2017","journal-title":"J Immunol Res."},{"issue":"10","key":"10.1111\/ajt.15397_bib4","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.1111\/j.1600-6143.2011.03640.x","article-title":"Revisiting traditional risk factors for rejection and graft loss after kidney transplantation","volume":"11","author":"Dunn","year":"2011","journal-title":"Am J Transplant."},{"issue":"8","key":"10.1111\/ajt.15397_bib5","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1681\/ASN.2009101065","article-title":"Preexisting donor-specific HLA antibodies predict outcome in kidney transplantation","volume":"21","author":"Lefaucheur","year":"2010","journal-title":"J Am Soc Nephrol."},{"issue":"12","key":"10.1111\/ajt.15397_bib6","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1681\/ASN.2012070664","article-title":"Donor-specific antibodies adversely affect kidney allograft outcomes","volume":"23","author":"Mohan","year":"2012","journal-title":"J Am Soc Nephrol."},{"issue":"12","key":"10.1111\/ajt.15397_bib7","doi-asserted-by":"crossref","first-page":"2684","DOI":"10.1111\/j.1600-6143.2008.02441.x","article-title":"Alloantibody levels and acute humoral rejection early after positive crossmatch kidney transplantation","volume":"8","author":"Burns","year":"2008","journal-title":"Am J Transplant."},{"issue":"2","key":"10.1111\/ajt.15397_bib8","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1097\/TP.0b013e3181919a16","article-title":"Living donor kidney transplantation across positive crossmatch: the University of Illinois at Chicago experience","volume":"87","author":"Thielke","year":"2009","journal-title":"Transplantation."},{"issue":"Suppl 4","key":"10.1111\/ajt.15397_bib9","first-page":"39","article-title":"Terminal complement inhibition decreases early acute humoral rejection in sensitized renal transplant recipients [abstract 1]","volume":"10","author":"Stegall","year":"2010","journal-title":"Am J Transplant."},{"issue":"1","key":"10.1111\/ajt.15397_bib10","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1097\/TP.0b013e318176ae2c","article-title":"Renal transplantation in patients with positive lymphocytotoxicity crossmatches: one center\u2019s experience","volume":"86","author":"Magee","year":"2008","journal-title":"Transplantation."},{"issue":"2","key":"10.1111\/ajt.15397_bib11","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1111\/j.1600-6143.2005.01178.x","article-title":"A comparison of plasmapheresis versus high-dose IVIG desensitization in renal allograft recipients with high levels of donor specific alloantibody","volume":"6","author":"Stegall","year":"2006","journal-title":"Am J Transplant."},{"issue":"9","key":"10.1111\/ajt.15397_bib12","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1097\/TP.0b013e3181d21e7f","article-title":"Use of intravenous immune globulin and rituximab for desensitization of highly HLA-sensitized patients awaiting kidney transplantation","volume":"89","author":"Vo","year":"2010","journal-title":"Transplantation."},{"issue":"2","key":"10.1111\/ajt.15397_bib13","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1111\/ajt.12982","article-title":"Quantifying renal allograft loss following early antibody-mediated rejection","volume":"15","author":"Orandi","year":"2015","journal-title":"Am J Transplant."},{"issue":"6","key":"10.1111\/ajt.15397_bib14","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1681\/ASN.2016070797","article-title":"Antibody-mediated rejection due to preexisting versus de novo donor-specific antibodies in kidney allograft recipients","volume":"28","author":"Aubert","year":"2017","journal-title":"J Am Soc Nephrol."},{"issue":"3","key":"10.1111\/ajt.15397_bib15","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/j.kint.2016.10.040","article-title":"Differences in pathologic features and graft outcomes in antibody-mediated rejection of renal allografts due to persistent\/recurrent versus de novo donor-specific antibodies","volume":"91","author":"Haas","year":"2017","journal-title":"Kidney Int."},{"issue":"2","key":"10.1111\/ajt.15397_bib16","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1007\/s40472-014-0012-y","article-title":"Acute antibody-mediated rejection in renal transplantation: current clinical management","volume":"1","author":"Schinstock","year":"2014","journal-title":"Curr Transplant Rep."},{"issue":"2","key":"10.1111\/ajt.15397_bib17","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1111\/ajt.12589","article-title":"Diagnosis and management of antibody-mediated rejection: current status and novel approaches","volume":"14","author":"Djamali","year":"2014","journal-title":"Am J Transplant."},{"issue":"4","key":"10.1111\/ajt.15397_bib18","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1097\/TP.0000000000002049","article-title":"The treatment of antibody-mediated rejection in kidney transplantation: an updated systematic review and meta-analysis","volume":"102","author":"Wan","year":"2018","journal-title":"Transplantation."},{"issue":"10","key":"10.1111\/ajt.15397_bib19","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1111\/tri.12621","article-title":"Difference in outcomes after antibody-mediated rejection between ABO-incompatible and positive cross-match transplantations","volume":"28","author":"Couzi","year":"2015","journal-title":"Transpl Int."},{"issue":"3","key":"10.1111\/ajt.15397_bib20","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1111\/j.1600-6143.2005.01214.x","article-title":"Intravenous gammaglobulin (IVIg): a novel approach to improve transplant rates and outcomes in highly HLA-sensitized patients","volume":"6","author":"Jordan","year":"2006","journal-title":"Am J Transplant."},{"key":"10.1111\/ajt.15397_bib21","doi-asserted-by":"crossref","first-page":"66","DOI":"10.3389\/fmed.2017.00066","article-title":"Complement in kidney transplantation","volume":"4","author":"Cernoch","year":"2017","journal-title":"Front Med."},{"issue":"9","key":"10.1111\/ajt.15397_bib22","doi-asserted-by":"crossref","first-page":"2589","DOI":"10.1111\/ajt.13797","article-title":"Targeting complement pathways during cold ischemia and reperfusion prevents delayed graft function","volume":"16","author":"Yu","year":"2016","journal-title":"Am J Transplant."},{"issue":"10","key":"10.1111\/ajt.15397_bib23","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1097\/TP.0000000000000184","article-title":"Report of the inefficacy of eculizumab in two cases of severe antibody-mediated rejection of renal grafts","volume":"98","author":"Burbach","year":"2014","journal-title":"Transplantation."},{"issue":"4","key":"10.1111\/ajt.15397_bib24","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1111\/tri.12706","article-title":"Complement inhibition as potential new therapy for antibody-mediated rejection","volume":"29","author":"Eskandary","year":"2016","journal-title":"Transpl Int."},{"key":"10.1111\/ajt.15397_bib25","first-page":"4","article-title":"Eculizumab for the treatment of severe antibody-mediated rejection: a case report and review of the literature","volume":"2016","author":"Tran","year":"2016","journal-title":"Case Rep Transplant."},{"issue":"11","key":"10.1111\/ajt.15397_bib26","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1111\/j.1600-6143.2011.03757.x","article-title":"Terminal complement inhibition decreases antibody-mediated rejection in sensitized renal transplant recipients","volume":"11","author":"Stegall","year":"2011","journal-title":"Am J Transplant."},{"issue":"5","key":"10.1111\/ajt.15397_bib27","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1111\/ajt.13168","article-title":"Positive crossmatch kidney transplant recipients treated with eculizumab: outcomes beyond 1 year","volume":"15","author":"Cornell","year":"2015","journal-title":"Am J Transplant."},{"issue":"4","key":"10.1111\/ajt.15397_bib28","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1111\/j.1600-6143.2008.02159.x","article-title":"Banff 07 classification of renal allograft pathology: updates and future directions","volume":"8","author":"Solez","year":"2008","journal-title":"Am J Transplant."},{"issue":"282","key":"10.1111\/ajt.15397_bib29","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","article-title":"Nonparametric estimation from incomplete observations","volume":"53","author":"Kaplan","year":"1958","journal-title":"J Am Stat Assoc."},{"key":"10.1111\/ajt.15397_bib30","doi-asserted-by":"crossref","unstructured":"Marks WH, Mamode N, Montgomery R, et al. Safety and efficacy of eculizumab in the prevention of antibody-mediated rejection in living-donor kidney transplant recipients requiring desensitization therapy: A randomized trial [published online ahead of print March 19, 2019]. Am J Transplant. https:\/\/doi.org\/10.1111\/ajt.15364.","DOI":"10.1111\/ajt.15364"},{"issue":"10","key":"10.1111\/ajt.15397_bib31","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1097\/00007890-200211270-00005","article-title":"Waiting time on dialysis as the strongest modifiable risk factor for renal transplant outcomes: a paired donor kidney analysis","volume":"74","author":"Meier-Kriesche","year":"2002","journal-title":"Transplantation."},{"issue":"2","key":"10.1111\/ajt.15397_bib32","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1053\/j.ajkd.2004.04.040","article-title":"Late urinary tract infection after renal transplantation in the United States","volume":"44","author":"Abbott","year":"2004","journal-title":"Am J Kidney Dis."},{"issue":"7","key":"10.1111\/ajt.15397_bib33","doi-asserted-by":"crossref","first-page":"515","DOI":"10.6061\/clinics\/2015(07)09","article-title":"Cytomegalovirus infection in transplant recipients","volume":"70","author":"Azevedo","year":"2015","journal-title":"Clinics."},{"issue":"1","key":"10.1111\/ajt.15397_bib34","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1097\/TP.0b013e31829434d4","article-title":"Early versus late acute antibody-mediated rejection in renal transplant recipients","volume":"96","author":"D\u00f6rje","year":"2013","journal-title":"Transplantation."},{"issue":"2","key":"10.1111\/ajt.15397_bib35","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1086\/313943","article-title":"Antifungal prophylaxis for solid organ transplant recipients: seeking clarity amidst controversy","volume":"31","author":"Singh","year":"2000","journal-title":"Clin Infect Dis."},{"issue":"1","key":"10.1111\/ajt.15397_bib36","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/tri.12413","article-title":"Cardiovascular morbidity and mortality after kidney transplantation","volume":"28","author":"Stoumpos","year":"2015","journal-title":"Transpl Int."},{"issue":"1 Suppl","key":"10.1111\/ajt.15397_bib37","doi-asserted-by":"crossref","first-page":"A7","DOI":"10.1053\/j.ajkd.2013.11.001","article-title":"US renal data system 2013 annual data report","volume":"63","author":"Collins","year":"2014","journal-title":"Am J Kidney Dis."},{"key":"10.1111\/ajt.15397_bib38","series-title":"Tacrolimus [Prescribing Information]","year":"2009"},{"key":"10.1111\/ajt.15397_bib39","series-title":"Mycophenolate Mofetil [Prescribing Information]","year":"2008"},{"issue":"23","key":"10.1111\/ajt.15397_bib40","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1056\/NEJMoa1208981","article-title":"Terminal complement inhibitor eculizumab in atypical hemolytic\u2013uremic syndrome","volume":"368","author":"Legendre","year":"2013","journal-title":"N Engl J Med."},{"issue":"5","key":"10.1111\/ajt.15397_bib41","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1038\/ki.2014.423","article-title":"Efficacy and safety of eculizumab in atypical hemolytic uremic syndrome from 2-year extensions of phase 2 studies","volume":"87","author":"Licht","year":"2015","journal-title":"Kidney Int."},{"issue":"12","key":"10.1111\/ajt.15397_bib42","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1056\/NEJMoa061648","article-title":"The complement inhibitor eculizumab in paroxysmal nocturnal hemoglobinuria","volume":"355","author":"Hillmen","year":"2006","journal-title":"N Engl J Med."},{"issue":"3","key":"10.1111\/ajt.15397_bib43","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1056\/NEJMoa0707894","article-title":"Rituximab and intravenous immune globulin for desensitization during renal transplantation","volume":"359","author":"Vo","year":"2008","journal-title":"N Engl J Med."},{"issue":"5","key":"10.1111\/ajt.15397_bib44","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1056\/NEJMoa1612567","article-title":"IgG endopeptidase in highly sensitized patients undergoing transplantation","volume":"377","author":"Jordan","year":"2017","journal-title":"N Engl J Med."},{"issue":"5","key":"10.1111\/ajt.15397_bib45","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1046\/j.1523-1755.2001.00030.x","article-title":"International variation in the interpretation of renal transplant biopsies: report of the CERTPAP Project","volume":"60","author":"Furness","year":"2001","journal-title":"Kidney Int."},{"issue":"12","key":"10.1111\/ajt.15397_bib46","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.2215\/CJN.06100617","article-title":"Association of kidney transplantation with survival in patients with long dialysis exposure","volume":"12","author":"Rose","year":"2017","journal-title":"Clin J Am Soc Nephrol."},{"issue":"3","key":"10.1111\/ajt.15397_bib47","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1111\/j.1600-6143.2009.02985.x","article-title":"Baseline donor-specific antibody levels and outcomes in positive crossmatch kidney transplantation","volume":"10","author":"Gloor","year":"2010","journal-title":"Am J Transplant."}],"container-title":["American Journal of Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fajt.15397","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/ajt.15397","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/ajt.15397","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1600613522092711?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1600613522092711?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/ajt.15397","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T05:24:24Z","timestamp":1761629064000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1600613522092711"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":47,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["S1600613522092711"],"URL":"https:\/\/doi.org\/10.1111\/ajt.15397","relation":{},"ISSN":["1600-6135"],"issn-type":[{"value":"1600-6135","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Safety and efficacy of eculizumab for the prevention of antibody-mediated rejection after deceased-donor kidney transplantation in patients with preformed donor-specific antibodies","name":"articletitle","label":"Article Title"},{"value":"American Journal of Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/ajt.15397","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2019 American Society of Transplantation & American Society of Transplant Surgeons. Published by Elsevier Inc. All rights reserved. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}